Summary for 9LSL
| Entry DOI | 10.2210/pdb9lsl/pdb |
| Descriptor | cGMP-specific 3',5'-cyclic phosphodiesterase, (13~{S},15~{R})-15-(3-chloranyl-4-methoxy-phenyl)-12-ethanoyl-8,12,16-triazatetracyclo[7.7.1.0^{2,7}.0^{13,17}]heptadeca-1(17),2,4,6,8-pentaene-4-carbonitrile, ZINC ION, ... (5 entities in total) |
| Functional Keywords | pde5a, hydrolase |
| Biological source | Homo sapiens (human) |
| Total number of polymer chains | 1 |
| Total formula weight | 38311.15 |
| Authors | |
| Primary citation | Wu, D.,Ma, Q.,Chen, Y.,Yang, G.,Zhang, F.,Jiang, M.,Wang, X.,Liu, X.,Zhou, Q.,Huang, Y.Y.,Li, Z.,Luo, H.B. Plasma metabolites-based drug design: Discovery of novel and highly selective phosphodiesterase 5 inhibitors Chin.Chem.Lett., :111236-, 2025 Cited by DOI: 10.1016/j.cclet.2025.111236PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (2.5 Å) |
Structure validation
Download full validation report






